Case Reports in Veterinary Medicine / 2014 / Article / Tab 3

Case Report

Failure of Miltefosine Treatment in Two Dogs with Natural Leishmania infantum Infection

Table 3

Case number 2: clinical score, therapy, and hematological and biochemical analysis of the second dog affected by canine leishmaniasis.

Follow-upClinical scoreTherapyRBC
×103/L
Hb
g/dL
PCV%PLT
/uL
TP
g/dL
ALB%G%A/GIFAT

D011/86MLT + A
28/d
510011.932288.0007.835.530.10.51 : 640
D307/86A536012.732.5272.0008.336.125.50.61 : 640
D903/86A655015.440.4186.0006.441.217.60.71 : 320
D1507/86MLT + A
28/d
597013.937.3172.0007.233.724.70.51 : 320
D18011/86MA
28/d
42808.926.3295.000837.626.40.61 : 320
D2105/86A647015.341.2197.0005.93219.80.51 : 320
D2702/86A670014.640.2307.0007.438.614.70.631 : 160
D4500/86A676014.542.7230.0006.946.313.90.71 : 160

RBC: red cells × 10/L (reference range 5700–8800 × 10/L).
Hemoglobin: Hb (reference range: 12.9–18.4 g/dL).
Haematocrit: PCV (reference range: 37.1–57%).
Platelet: PLT (reference range: 143300–400000/uL).
Total protein: TP (reference range: 6–8 g/dL).
Albumine: ALB (reference range: 46.3–58.5%).
Gamma globuline: G (reference range: 5.3–9.9%).
Albumine/globuline: A/G (reference rang: 0.8–1.7).
IFAT: immunofluorescence antibody test (reference range: <1 : 80).
Miltefosine: MLT.
Allopurinol: A.
Meglumine antimoniate: MA.
Days: d.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.